Achelous’ Transactions

Achelous Partners has selected the following announced M&A transactions and advisory work to illustrate our client commitment and our expertise in a variety of life science and healthcare fields.

June 2025

The undersigned acted as financial advisor to Plasma Services Group

June 2025
June 2025

has been acquired by

June 2025
January 2025

The undersigned acted as financial advisor to BioTeknica Inc.

January 2025
January 2025

has been acquired by

January 2025
June 2024

This acquisition will likely strengthen Siegfried’s position in the North American market and enhance its manufacturing capacity and services.

June 2024
June 2024

Wisconsin CDMO site is
being acquired by

June 2024
May 2024

The undersigned acted as financial advisor to Metabolic Solutions

May 2024
May 2024

has been acquired by

May 2024
April 2024

The undersigned acted as financial advisor to A4P Consulting

April 2024
April 2024

has been acquired by

April 2024
March 2024

The undersigned acted as financial advisor to Six Degrees Medical

March 2024
March 2024

has been acquired by

March 2024
December 2023

The undersigned acted as financial advisor to Bio X Cell, LLC

December 2023
December 2023

has been acquired by

December 2023
November 2023

The undersigned acted as financial advisor to Symbio LLC

November 2023
November 2023

has been acquired by

November 2023
November 2023

The undersigned acted as financial advisor to Proinnovera, GmbH

November 2023
November 2023

has been acquired by

November 2023
December 2023

The undersigned acted as financial advisor to Pharmalog, GmbH

December 2023
December 2023

has been acquired by

December 2023
January 2023

The undersigned acted as financial advisor to ECIR Medical Communications Inc.

January 2023
January 2023

has been acquired by

January 2023
January 2023

The undersigned acted as financial advisor to Alcedis, GmbH

January 2023
January 2023

has been acquired by

January 2023
November 2022

The undersigned acted as financial advisor to Expression Systems, LLC

November 2022
November 2022

has been acquired by

November 2022
October 2022

The undersigned acted as financial advisor to AQW Holdings, Inc. d.b.a. Qfix

October 2022
October 2022

has been acquired by

October 2022
August 2022

The undersigned acted as financial advisor to AusDiagnostics

August 2022
August 2022

has been acquired by

August 2022
July 2022

The undersigned acted as financial advisor to Cergentis B.V.

July 2022
July 2022

has been acquired by

July 2022
July 2022

The undersigned acted as financial advisor to proderm GmbH

July 2022
July 2022

has been acquired by

July 2022
June 2022

The undersigned acted as financial advisor to SAI MedPartners

June 2022
June 2022

has been acquired by

June 2022
December 2023

The undersigned acted as financial advisor to TCP Analytical

December 2023
December 2023

has acquired

December 2023
November 2021

The undersigned acted as financial advisor to Regulatory Compliance Associates Inc.

November 2021
November 2021

has been acquired by

November 2021
August 2021

The undersigned acted as financial advisor to DRG International Inc.

August 2021
August 2021

has been acquired by

August 2021
August 2021

The undersigned acted as financial advisor to bioskin GmbH

August 2021
August 2021

has been acquired by

August 2021
July 2021

The undersigned acted as financial advisor to nanoComposix Holdings, Inc.

July 2021
July 2021

has been acquired by

July 2021
May 2021

The undersigned acted as financial advisor to Clinical Outcomes Solutions

May 2021
May 2021

has been acquired by

May 2021
March 2021

The undersigned acted as financial advisor to Diamond Pharma Services

March 2021
March 2021

has been acquired by

March 2021
February 2021

The undersigned acted as financial advisor to Delphi Genetics

February 2021
February 2021

has been acquired by

February 2021
October 2020

The undersigned acted as financial advisor to MD Biosciences, Inc.

October 2020
October 2020

has been acquired by

October 2020
September 2020

The undersigned acted as financial advisor to American Laboratory Products Company, Ltd.

September 2020
September 2020

has been acquired by

September 2020
September 2020

The undersigned acted as financial advisor to Maetrics LLC

September 2020
September 2020

has been acquired by

September 2020
August 2020

The undersigned acted as financial advisor to CTK Biotech, Inc.

August 2020
August 2020

has been acquired by

August 2020
February 2020

The undersigned acted as financial advisor to BresMed Health Solutions Ltd

February 2020
February 2020

has been acquired by

February 2020
January 2020

The undersigned acted as financial advisor to Statistics Collaborative, Inc.

January 2020
January 2020

has been acquired by

January 2020
December 2019

The undersigned acted as financial advisor to MLM Medical Labs GmbH

December 2019
December 2019

has been acquired by

December 2019
October 2019

The undersigned acted as financial advisor to Specialized Medical Services-oncology BV

October 2019
October 2019

has been acquired by

October 2019
July 2019

The undersigned acted as financial advisor to Eurolyser Diagnostica GmbH

July 2019
July 2019

has been acquired by

July 2019
July 2019

The undersigned acted as financial advisor to LifeSpan BioSciences

July 2019
July 2019

has acquired

July 2019
March 2019

The undersigned acted as financial advisor to Quorum Review, Inc.

March 2019
March 2019

has been acquired by

March 2019
January 2019

The undersigned acted as financial advisor to ProductLife Group

January 2019
January 2019

has been acquired by

January 2019
January 2019

The undersigned acted as financial advisor to CoreBiome, Inc.

January 2019
January 2019

has been acquired by

January 2019
October 2018

The undersigned acted as financial advisor to Pennside Partners Ltd.

October 2018
October 2018

has been acquired by

October 2018
September 2018

The undersigned acted as financial advisor to NovaTec Immundiagnostica GmbH

September 2018
September 2018

has been acquired by

September 2018
September 2018

The undersigned acted as financial advisor to Thompson Street Capital Partners

September 2018
September 2018

has acquired

September 2018
September 2018

The undersigned served as financial advisor to HyTest Ltd.

September 2018
September 2018

has been acquired by

September 2018
July 2018

The undersigned served as financial advisor to Gold Standard Diagnostics Corp.

July 2018
July 2018

has been acquired by

July 2018
May 2018

The undersigned served as financial advisor to Biovian Oy

May 2018
May 2018

has been acquired by

May 2018
January 2018

The undersigned served as financial advisor to LifeCodexx AG

January 2018
January 2018

has been acquired by

January 2018
June 2017

The undersigned acted as financial advisor to Coté Orphan, LLC

June 2017
June 2017

has been acquired by

June 2017
May 2017

The undersigned acted as financial advisor to PharmaCell B.V.

May 2017
May 2017

has been acquired by

May 2017
April 2017

The undersigned acted as financial advisor to Emergo Group, Inc.

April 2017
April 2017

has been acquired by

April 2017
April 2017

The undersigned acted as financial advisor to Calbiotech, Inc.

April 2017
April 2017

has been acquired by

April 2017
January 2017

The undersigned acted as financial advisor to BioControl Systems, Inc.

January 2017
January 2017

has been acquired by

January 2017
August 2016

The undersigned acted as financial advisor to SPEware Corporation

August 2016
August 2016

has been acquired by

August 2016
July 2016

The undersigned acted as financial advisor to Sharps Compliance Corp.

July 2016
July 2016

has acquired

July 2016
June 2016

The undersigned acted as financial advisor to Cisbio Bioassays

June 2016
June 2016

has been acquired by

June 2016
December 2015

The undersigned acted as financial advisor to Abzena plc

December 2015
December 2015

has acquired

December 2015
December 2015

The undersigned acted as financial adviser to Sharps Compliance Corp.

December 2015
December 2015

has acquired

December 2015
October 2015

The undersigned acted as financial advisor to Kinesis Pharma BV

October 2015
October 2015

has been acquired by

October 2015
August 2015

The undersigned acted as financial advisor to DIAsource ImmunoAssays SA

August 2015
August 2015

has been acquired by

August 2015
July 2015

The undersigned acted as financial advisor to Sharps Compliance Corp.

July 2015
July 2015

has acquired

July 2015
March 2015

The undersigned acted as financial advisor to Ansell Limited

March 2015
March 2015

has acquired

March 2015
July 2014

The undersigned acted as financial advisor to IBL International Holding BV

July 2014
July 2014

has been acquired by

July 2014
July 2014

The undersigned served as financial advisor to Phlexglobal Limited

July 2014
July 2014

has been acquired by

July 2014
June 2014

The undersigned acted as financial advisor to Spectris plc

June 2014
June 2014

has acquired

June 2014
June 2014

The undersigned served as financial advisors to Pharmalink Consulting

June 2014
June 2014

has been acquired by

June 2014
December 2013

The undersigned acted as advisor to Valeant Pharmaceuticals International

December 2013
December 2013

has acquired assets from

December 2013
August 2013

The undersigned acted as financial advisor to Kirkegaard & Perry Laboratories Inc

August 2013
August 2013

has been acquired by

August 2013
July 2013

The undersigned acted as financial advisor to The Anson Group LLC

July 2013
July 2013

has been acquired by

July 2013
July 2013

an Apax Partners company The undersigned acted as financial advisor to Austofix Group Limited

July 2013
July 2013

has signed a definitive agreement to sell its orthopedic implant assets and business to

July 2013
July 2013

The undersigned acted as financial advisor to Kreatech Holding B.V.

July 2013
July 2013

has been acquired by

July 2013
July 2013

The undersigned acted as financial advisor to Matrical Bioscience Inc

July 2013
July 2013

has been acquired by

July 2013
May 2013

The undersigned acted as advisor to Triangle Biomedical Sciences Inc.

May 2013
May 2013

has been acquired by

May 2013
August 2012

The undersigned acted as advisor to JSW Life Sciences GmbH

August 2012
August 2012

has been acquired by

August 2012
March 2012
US$164M plus up to US$20M in milestones
The undersigned acted as advisor to Valeant Pharmaceuticals International
March 2012
March 2012

has acquired assets from

March 2012
December 2011

The undersigned acted as advisor to Ansell Limited for the investment

December 2011
December 2011

invests in

December 2011
August 2010

The undersigned acted as financial advisor to EnviroLogix, Inc.

August 2010
August 2010

has been acquired by

August 2010
March 2010

The undersigned acted as financial advisor to Finnzymes Oy

March 2010
March 2010

has been acquired by

March 2010
December 2009

The undersigned acted as financial advisor to BTG olc

December 2009
December 2009

has licensed its ReGet® drug delivery system for ophthalmic indications to

December 2009
October 2009

The undersigned acted as financial advisor to Anaspec Inc.

October 2009
October 2009

has been acquired by

October 2009
August 2009

The undersigned acted as financial advisor to BTG plc

August 2009
August 2009

has sold its HySolv™ drug delivery technology to

August 2009
January 2009

The undersigned acted as financial advisor to the shareholders of Labcoat Limited

January 2009
January 2009

has been acquired by

January 2009
December 2008

The undersigned is acting as financial advisor to Biocompatibles International

December 2008
December 2008

has acquired

December 2008
December 2008

The undersigned rendered a Fairness Opinion to Affymetrix, Inc.

December 2008
December 2008

has acquired

December 2008
February 2008

The undersigned is acting as financial advisor to Sigma Pharmaceuticals

February 2008
February 2008

has been acquired by

February 2008
January 2008

The undersigned is acting as financial advisor to Panbio Limited

January 2008
January 2008

has been acquired by

January 2008
May 2007

The undersigned acted as financial advisor to Ansell Limited

May 2007
May 2007

has acquired

May 2007
March 2007

The undersigned acted as financial advisor to Agenix Limited

March 2007
March 2007

has sold its Human Health point-of-care diagnostic products business to

March 2007
February 2007

The undersigned acted as financial advisor to GeneMedix, PLC

February 2007
February 2007

Strategic alliance and investment of up to £32,100,000 in

February 2007
December 2006

The undersigned acted as financial advisor to Panbio Limited

December 2006
December 2006

Announced M&A advisory and restructuring

December 2006
December 2006

The undersigned acted financial advisor to Novozymes A/S

December 2006
December 2006

has acquired

December 2006
August 2006

The undersigned acted as financial advisor to Meditech Research Limited

August 2006
August 2006

has acquired

August 2006
July 2006

The undersigned acted as financial advisor to Novozymes A/S

July 2006
July 2006

has acquired Delta Biotechnology Ltd from

July 2006
April 2006

The undersigned acted as financial advisor to Agenix Limited

April 2006
April 2006

has assigned IP and granted distribution rights for its Animal Health business to

April 2006
October 2005

The undersigned acted as financial advisor to CogState Limited

October 2005
October 2005

M&A advisory and valuation analysis

October 2005
September 2005

The undersigned acted as advisor to Genetic Technologies Limited

September 2005
September 2005

NASDAQ listing of ADRs (American Depositary Receipts)

September 2005
June 2005

The undersigned acted as advisor to ChemGenex Pharmarceuticals Limited

June 2005
June 2005

NASDAQ listing of ADRs (American Depositary Receipts)

June 2005
January 2005

for its investment banking role in the creation

January 2005
January 2005

awarded to

January 2005
December 2004

The undersigned acted as financial advisor to AGT Biosciences Ltd.

December 2004
December 2004

has been acquired by

December 2004

Get in Touch

Get Expert Advice and
Propel Your Business Forward

Ready to take your business to the next level? Our team of experts are here to provide the strategic advice and tailored solutions you need to excel.